On May 3, 2023, a high-profile case at the Patent Trial & Appeal Board (PTAB) saw Spectrum Solutions LLC being granted a motion for sanctions against Longhorn Vaccines & Diagnostics LLC[ref]. The resulting sanctions order brought about the cancellation of five Longhorn patents in an outcome that stirred the patent law industry.
The Board found that Longhorn had not met its duty of candor, a critical aspect of patent law proceedings. This was due to Longhorn’s selective and improper withholding of results that went against its patentability claims. The canceled patents covered chemical compositions, collection systems and methods which Longhorn had made arguments for.
The verdict has caused upheaval and led to the Director of the United States Patent and Trademark Office (PTO) seeking input on this decision. This indicates the decision’s potential for setting a new precedent due to its significant concern over the duty of candor in patent law proceedings.
The PTO Director’s request for input is a clear sign of the intricacy and the potential impact of the PTAB’s ruling. It signifies a need for wider discussion and illumination, especially among corporations and law firms directly involved in patent law.
Corporate legal teams, patent law professionals and stakeholders must closely monitor this development to understand the possible changes the patent law landscape could be facing. Comments requested by the PTO Director will undoubtedly lead to crucial insights and may outline potential path for this complex, yet vital legal issue.